Singapore's GIC invests in German pharma company Cheplapharm

CEBU, Philippines -- German pharmaceutical Cheplapharm says it has raised 550 million euros ($547 million) in structured investment from Singapore sovereign wealth fund GIC and Atlantic Park.

Singapore's GIC invests in German pharma company Cheplapharm

Read Next

South Korea's Nextrans to launch $50m Vietnam-focused fund

Grab to close cloud kitchen services in Indonesia

Singapore-based sneaker brand Cariuma steps up funding

Chinese battery startup Hithium raises $278m to boost output

South Korea pizza chain raises $25m for bigger slice of India market

U.S. venture capital firm investing in Asia seeks $1bn for funds

Australian Fintech Airwallex raises another $100m

Thai online beauty retailer Konvy raises $10m from Insignia Ventures

Dutch FMO proposes $10m investment in Sri Lanka seafood exporter

Singapore's GIC leads $60m funding for Indian EV maker Euler

Singapore cashback platform ShopBack gets $80m from Temasek arm

Singapore's Affirma targets first Southeast Asia-focused fund

Chinese biopharma Taibang raises $300m, stirs relisting murmurs

Singapore's GIC: downturn in tech, crypto funding 'a good thing'

Latest on DealStreetAsia

Vietnam prepares startup stock trading platform in innovation push

Philippine tax cuts spur hope for more IPOs in sluggish market

Vietnam's fintech unicorn MoMo posts first full-year profit

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.